Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20200901005308/en/NeuClone-Discloses-Biosimilars-Referencing-Opdivo%C2%AE-Keytruda%C2%AE#:~:text=NeuClone%20Discloses%20Two%20Biosimilars%20Referencing%20Opdivo%C2%AE%20and%20Keytruda,-%C2%AE&text=These%20biosimilars%20reference%20two%20antibody,patients%20across%20multiple%20oncology%20settings.
https://www.businesswire.com/news/home/20200408005128/en/NeuClone-Announces-Completion-Subject-Visits-Stelara%C2%AE-ustekinumab/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://www.businesswire.com/news/home/20191218005072/en/%E2%80%8BNeuClone-Completes-Dosing-Phase-Clinical-Trial-Stelara%C2%AE